Guo, J.; Yang, Q.; Jiang, Q.; Gu, L.-W.; Lin, H.-X.; Guo, L.
Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor. Nutrients 2023, 15, 4262.
https://doi.org/10.3390/nu15194262
AMA Style
Guo J, Yang Q, Jiang Q, Gu L-W, Lin H-X, Guo L.
Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor. Nutrients. 2023; 15(19):4262.
https://doi.org/10.3390/nu15194262
Chicago/Turabian Style
Guo, Jia, Qi Yang, Qi Jiang, Li-Wen Gu, Huan-Xin Lin, and Ling Guo.
2023. "Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor" Nutrients 15, no. 19: 4262.
https://doi.org/10.3390/nu15194262
APA Style
Guo, J., Yang, Q., Jiang, Q., Gu, L.-W., Lin, H.-X., & Guo, L.
(2023). Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor. Nutrients, 15(19), 4262.
https://doi.org/10.3390/nu15194262